Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) for metastatic urothelial carcinoma (mUC) treatment-experienced (DAD) and with pembrolizumab (P) in treatment naive UC (DAD-IO)
Meeting Abstract
Overview
Research
Additional Document Info
View All
Overview
cited authors
McGregor, Bradley Alexander; Kwak, Lucia; Sonpavde, Guru P.; Berg, Stephanie A.; Choueiri, Toni K.; Bellmunt, Joaquim; Mantia, Charlene
Publication Date
June 1, 2024
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
Additional Document Info
volume
42
issue
16